0001707597-18-000002.txt : 20180307 0001707597-18-000002.hdr.sgml : 20180307 20180307151033 ACCESSION NUMBER: 0001707597-18-000002 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20180307 DATE AS OF CHANGE: 20180307 EFFECTIVENESS DATE: 20180307 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Koligo Therapeutics Inc. CENTRAL INDEX KEY: 0001707597 IRS NUMBER: 811717874 STATE OF INCORPORATION: KY FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-307135 FILM NUMBER: 18673105 BUSINESS ADDRESS: STREET 1: 632 RUSSELL ST CITY: COVINGTON STATE: KY ZIP: 41011 BUSINESS PHONE: 6463317899 MAIL ADDRESS: STREET 1: 632 RUSSELL ST CITY: COVINGTON STATE: KY ZIP: 41011 D 1 primary_doc.xml X0708 D LIVE 0001707597 Koligo Therapeutics Inc. 204 South Floyd St. Louisville KY KENTUCKY 40202 5022425890 KENTUCKY None None Corporation true 2016 Matthew B Lehman 204 South Floyd St Louisville KY KENTUCKY 40202 Executive Officer Director David Blanford 204 South Floyd St Louisville KY KENTUCKY 40202 Executive Officer Director Stuart Williams 204 South Floyd St Louisville KY KENTUCKY 40202 Executive Officer Director Balamurugan Appakalai 204 South Floyd St Louisville KY KENTUCKY 40202 Executive Officer Director Michael Hughes 204 South Floyd St Louisville KY KENTUCKY 40202 Executive Officer Director Biotechnology $1 - $1,000,000 06b false 2018-03-06 false true true false 0 2000000 2000000 0 false 1 0 0 100000 true false Koligo Therapeutics Inc. Matthew Lehman Matthew Lehman CEO 2018-03-07